This retrospective study found no benefit of a disease management program compared with usual care on utilization of secondary prevention pharmacotherapies in postmyocardial infarction patients.
Vicky Chan, PharmD
Advertisement
Articles by Vicky Chan, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
PBM Reform and Supportive Care Needs: Nicolas Ferreyros
2
5 Things to Know About the One Big Beautiful Bill Act
3
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
4
Genetic Analysis Links Insomnia Liability to Higher Inflammation Marker
5